T-cell activation: A multidimensional signaling network

Current Opinion in Cell Biology

Volumn 14, Issue 5, 2002, Pages 575-580

  Tseng, Su Yi ^a   Dustin, Michael L ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE ANTIGEN RECEPTOR; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; PROTEIN TYROSINE KINASE; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANTIGEN PRESENTING CELL; CELL DIFFERENTIATION; CELL INTERACTION; CELL MIGRATION; CELL PROLIFERATION; LYMPH NODE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

ANIMALIA;

EID: 0036774278     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-0674(02)00370-8     Document Type: Review

References (59)

1. Babbitt B.P., Allen P.M., Matsueda G., Haber E., Unanue E.R. Binding of immunogenic peptides to Ia histocompatibility molecules. Nature. 317:1985;359-361.
2. Forster R., Schubel A., Breitfeld D., Kremmer E., Renner-Muller I., Wolf E., Lipp M. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell. 99:1999;23-33.
3. Farrar J.D., Asnagli H., Murphy K. T helper subset development: roles of instruction, selection, and transcription. J Clin Invest. 109:2002;431-435.
4. Dustin M.L., Allen P.M., Shaw A. Environmental control of immunological synapse formation and duration. Trends Immunol. 22:2001;192-194.
5. Luther S.A., Lopez T., Bai W., Hanahan D., Cyster J.G. BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis. Immunity. 12:2000;471-481.
6. Baekkevold E.S., Yamanaka T., Palframan R.T., Carlsen H.S., Reinholt F.P., von Andrian U.H., Brandtzaeg P., Haraldsen G. The CCR7 ligand ELC (CCL19) is transcytosed in high endothelial venules and mediates T cell recruitment. J Exp Med. 193:2001;1105-1112. The authors showed that engagement of ELC (Epstein-Barr virus-inducible molecule 1 ligand chemokine, or CCL19) and CCR7 plays a role in arresting migrating T cells and homes them to the lymph node.
7. Palecek S.P., Schmidt C.E., Lauffenburger D.A., Horwitz A.F. Integrin dynamics on the tail region of migrating fibroblasts. J Cell Sci. 109:1996;941-952.
8. Verkhovsky A.B., Svitkina T.M., Borisy G.G. Polarity sorting of actin filaments in cytochalasin-treated fibroblasts. J Cell Sci. 110:1997;1693-1704.
9. Grakoui A., Bromley S.K., Sumen C., Davis M.M., Shaw A.S., Allen P.M., Dustin M.L. The immunological synapse: a molecular machine controlling T cell activation. Science. 285:1999;221-227.
10. Monks C.R., Freiberg B.A., Kupfer H., Sciaky N., Kupfer A. Three-dimensional segregation of supramolecular activation clusters in T cells. Nature. 395:1998;82-86.
11. Krummel M.F., Sjaastad M.D., Wulfing C., Davis M.M. Differential clustering of CD4 and CD3zeta during T cell recognition. Science. 289:2000;1349-1352.
12. Dustin M.L., Olszowy M.W., Holdorf A.D., Li J., Bromley S., Desai N., Widder P., Rosenberger F., van der Merwe P.A., Allen P.M., Shaw A.S. A novel adaptor protein orchestrates receptor patterning and A novel adaptor protein orchestrates receptor patterning and cytoskeletal polarity in T-cell contacts. Cell. 94:1998;667-677.
13. Lee K.H., Holdorf A.D., Dustin M.L., Chan A.C., Allen P.M., Shaw A.S. T cell receptor signaling precedes immunological synapse formation. Science. 295:2002;1539-1542.
14. Gunzer M., Schafer A., Borgmann S., Grabbe S., Zanker K.S., Brocker E.B., Kampgen E., Friedl P. Antigen presentation in extracellular matrix: interactions of T cells with dendritic cells are dynamic, short lived, and sequential. Immunity. 13:2000;323-332.
15. Bromley S.K., Peterson D.A., Gunn M.D., Dustin M.L. Cutting edge: hierarchy of chemokine receptor and TCR signals regulating T cell migration and proliferation. J Immunol. 165:2000;15-19.
16. Stoll S., Delon J., Brotz T.M., Germain R.N. Dynamic imaging of T Cell-dendritic cell interactions in lymph nodes. Science. 296:2002;1873-1876.
17. Miller M.J., Wei S.H., Parker I., Cahalan M.D. Two-photon imaging of lymphocyte motility and antigen response in intact lymph node. Science. 296:2002;1869-1873.
18. Harding F.A., McArthur J.G., Gross J.A., Raulet D.H., Allison J.P. CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature. 356:1992;607-609.
19. Linsley P.S., Brady W., Grosmaire L., Aruffo A., Damle N.K., Ledbetter J.A. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J Exp Med. 173:1991;721-730.
20. Thompson C.B., Lindsten T., Ledbetter J.A., Kunkel S.L., Young H.A., Emerson S.G., Leiden J.M., June C.H. CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines. Proc Natl Acad Sci USA. 86:1989;1333-1337.
21. Fraser J.D., Irving B.A., Crabtree G.R., Weiss A. Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28. Science. 251:1991;313-316.
22. Lindstein T., June C.H., Ledbetter J.A., Stella G., Thompson C.B. Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science. 244:1989;339-343.
23. Boise L.H., Minn A.J., Noel P.J., June C.H., Accavitti M.A., Lindsten T., Thompson C.B. CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. Immunity. 3:1995;87-98.
24. Chambers C.A., Kuhns M.S., Egen J.G., Allison J.P. CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy. Annu Rev Immunol. 19:2001;565-594.
25. Linsley P.S., Brady W., Urnes M., Grosmaire L.S., Damle N.K., Ledbetter J.A. CTLA-4 is a second receptor for the B cell activation antigen B7. J Exp Med. 174:1991;561-569.
26. Waterhouse P., Marengere L.E., Mittrucker H.W., Mak T.W. CTLA-4, a negative regulator of T-lymphocyte activation. Immunol Rev. 153:1996;183-207.
27. Bromley S.K., Iaboni A., Davis S.J., Whitty A., Green J.M., Shaw A.S., Weiss A., Dustin M.L. The immunological synapse and CD28-CD80 interactions. Nat Immunol. 2:2001;1159-1166. Using the bilayer system, these authors showed that engagement of the co-stimulatory molecule CD80 coincides with formation of the central supermolecular activation cluster in the immunological synapse. Co-stimulation had no effect on immunological synapse formation, but increased the efficacy of the immunological synapses in terms of T-cell proliferation.
28. Holdorf A.D., Lee K.H., Burack W.R., Allen P.M., Shaw A.S. Regulation of Lck activity by CD4 and CD28 in the immunological synapse. Nat Immunol. 3:2002;259-264. These authors showed that CD28 engagement with its ligand plays a role in regulating a tyrosine phosphatase, Lck, during T-cell activation.
29. Wulfing C., Davis M.M. A receptor/cytoskeletal movement triggered by costimulation during T cell activation. Science. 282:1998;2266-2269.
30. Viola A., Schroeder S., Sakakibara Y., Lanzavecchia A. T lymphocyte costimulation mediated by reorganization of membrane microdomains. Science. 283:1999;680-682.
31. Turley S.J., Inaba K., Garrett W.S., Ebersold M., Unternaehrer J., Steinman R.M., Mellman I. Transport of peptide-MHC class II complexes in developing dendritic cells. Science. 288:2000;522-527. This work showed that CD80 colocalizes with MHC class II molecules in transport vesicles, termed CIIVs, in dendritic cells.
32. Kropshofer H., Spindeldreher S., Rohn T.A., Platania N., Grygar C., Daniel N., Wolpl A., Langen H., Horejsi V., Vogt A.B. Tetraspan microdomains distinct from lipid rafts enrich select peptide-MHC class II complexes. Nat Immunol. 3:2002;61-68.
33. Dong H., Zhu G., Tamada K., Chen L. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat Med. 5:1999;1365-1369.
34. Freeman G.J., Long A.J., Iwai Y., Bourque K., Chernova T., Nishimura H., Fitz L.J., Malenkovich N., Okazaki T., Byrne M.C., et al. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation [In Process Citation]. J Exp Med. 192:2000;1027-1034.
35. Tamura H., Dong H., Zhu G., Sica G.L., Flies D.B., Tamada K., Chen L. B7-H1 costimulation preferentially enhances CD28-independent T-helper cell function. Blood. 97:2001;1809-1816. Using CD28-null APCs, the authors showed that B7-H1 co-stimulation enhances T-helper cell function independently of CD28.
36. Tseng S.Y., Otsuji M., Gorski K., Huang X., Slansky J.E., Pai S.I., Shalabi A., Shin T., Pardoll D.M., Tsuchiya H. B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells. J Exp Med. 193:2001;839-846.
37. Latchman Y., Wood C.R., Chernova T., Chaudhary D., Borde M., Chernova I., Iwai Y., Long A.J., Brown J.A., Nunes R., et al. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat Immunol. 2:2001;261-267.
38. Nishimura H., Okazaki T., Tanaka Y., Nakatani K., Hara M., Matsumori A., Sasayama S., Mizoguchi A., Hiai H., Minato N., Honjo T. Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science. 291:2001;319-322.
39. Nishimura H., Minato N., Nakano T., Honjo T. Immunological studies on PD-1 deficient mice: implication of PD-1 as a negative regulator for B cell responses. Int Immunol. 10:1998;1563-1572.
40. Tivol E.A., Borriello F., Schweitzer A.N., Lynch W.P., Bluestone J.A., Sharpe A.H. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multi-organ tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity. 3:1995;541-547.
41. Swallow M.M., Wallin J.J., Sha W.C. B7h, a novel costimulatory homolog of B7.1 and B7.2, is induced by TNFalpha. Immunity. 11:1999;423-432.
42. Yoshinaga S.K., Whoriskey J.S., Khare S.D., Sarmiento U., Guo J., Horan T., Shih G., Zhang M., Coccia M.A., Kohno T., et al. T-cell co-stimulation through B7RP-1 and ICOS. Nature. 402:1999;827-832.
43. Hutloff A., Dittrich A.M., Beier K.C., Eljaschewitsch B., Kraft R., Anagnostopoulos I., Kroczek R.A. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature. 397:1999;263-266.
44. McAdam A.J., Chang T.T., Lumelsky A.E., Greenfield E.A., Boussiotis V.A., Duke-Cohan J.S., Chernova T., Malenkovich N., Jabs C., Kuchroo V.K., Ling V., et al. Mouse inducible costimulatory molecules (ICOS) expression is enhanced by CD28 costimulation and regulates differentiation of CD4+ T cells. J Immunol. 165:2000;5035-5040.
45. Dong C., Juedes A.E., Temann U., Shresta S., Allison J.P., Ruddle N.H., Flavell R. ICOS co-stimulatory receptor is essential for T-cell activation and function. Nature. 409:2001;97-101.
46. McAdam A.J., Greenwald R.J., Levin M.A., Chernova T., Malenkovich N., Ling V., Freeman G.J., Sharpe A.H. ICOS is critical for CD-40-mediated antibody class switching. Nature. 409:2001;102-105.
47. Tafuri A., Shahinian A., Bladt F., Yoshinaga S.K., Jordana M., Wakeham A., Boucher L., Bouchard D., Chan V.S.F., Duncan G., Odermatt B., et al. ICOS is essential for effective T-helper-cell responses. Nature. 409:2001;105-109.
48. Ozkaynak E., Gao W., Shemmeri N., Wang C., Gutierrez-Ramos J.C., Amaral J., Qin S., Rottman J.B., Coyle A.J., Hancock W.W. Importance of ICOS-B7RP-1 costimulation in acute and chronic allograft rejection. Nat Immunol. 2:2001;591-596.
49. Mosmann T.R., Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today. 17:1996;138-146.
50. Iezzi G., Scheidegger D., Lanzavecchia A. Migration and function of antigen-primed nonpolarized T lymphocytes in vivo. J Exp Med. 193:2001;987-993. This paper showed that non-polarized T cells and Th1 and Th2 cells have different migratory capacities for the lymph node. Specifically, naïve and non-polarized T cells home to the lymphnode and non-polarized T cells have non-polarized T cells home to the lymphnode and non-polarized T cells have faster kinetics than naïve T cells for T-cell activation and differentiation.
51. Iezzi G., Karjalainen K., Lanzavecchia A. The duration of antigenic stimulation determines the fate of naive and effector T cells. Immunity. 8:1998;89-95.
52. Egen J.G., Allison J.P. Cytotoxic T lymphocyte antigen-4 accumulation in the immunological synapse is regulated by TCR signal strength. Immunity. 16:2002;23-35. The authors showed that CTLA-4 was recruited to the immunological synapse in response to strong agonist ligands, but not weak agonist ligands, while CD28 was recruited with both types of agonists.
53. Ingulli E., Mondino A., Khoruts A., Jenkins M.K. In vivo detection of dendritic cell antigen presentation to CD4(+) T cells. J Exp Med. 185:1997;2133-2141.
54. Lanzavecchia A., Sallusto F. From synapses to immunological memory: the role of sustained T cell stimulation. Curr Opin Immunol. 12:2000;92-98.
55. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature. 392:1998;245-252.
56. Mages H.W., Hutloff A., Heuck C., Buchner K., Himmelbauer H., Oliveri F., Kroczek R.A. Molecular cloning and characterization of murine ICOS and identification of B7h as ICOS ligand. Eur J Immunol. 30:2000;1040-1047.
57. Carter L., Fouser L.A., Jussif J., Fitz L., Deng B., Wood C.R., Collins M., Honjo T., Freeman G.J., Carreno B.M. PD-1: PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2. Eur J Immunol. 32:2002;634-643.
58. Lindsten T., Lee K.P., Harris E.S., Petryniak B., Craighead N., Reynolds P.J., Lombard D.B., Freeman G.J., Nadler L.M., Gray G.S., et al. Characterization of CTLA-4 structure and expression on human T cells. J Immunol. 151:1993;3489-3499.
59. Krummel M.F., Allison J.P. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J Exp Med. 182:1995;459-465.